Journal of the American Chemical Society · 2004 · 40 citations · 9 references
Life SciencesBiochemistryPharmacologyDrug DiscoveryEnzyme MechanismEnzymologyAntimicrobial PeptidesCatalytic MechanismsEnzymatic Cleavage StrategiesEnzyme FunctionEnzyme InhibitionEnzyme TargetsActive Site InhibitorsAminoglycoside AntibioticsCatalytic ActivityEnzyme Inhibition ScreeningProteolytic ActivityProteolytic Enzyme ActivityProteolytic PathwaysRna Targeting
The anthrax lethal factor (LF), a Zn-dependent endopeptidase, is considered the dominant virulence factor of anthrax. Because pharmacological inhibition of the catalytic activity of LF is considered a plausible mechanism for preventing the lethality of anthrax, a high-throughput screening experiment based on LF-catalyzed cleavage of a fluorescent substrate was performed to identify novel inhibitors of LF. The RNA-targeting antibiotics, neomycin B and some synthetic dimeric aminoglycosides, were found to be nanomolar active-site inhibitors of LF.
9
Proteolytic Inactivation of MAP-Kinase-Kinase by Anthrax Lethal Factor
Nicholas S. Duesbery, Craig P. Webb, Stephen H. Leppla et al. · Science · 1998 · 1K citations
Crystal structure of the anthrax lethal factor
Andrew Pannifer, Robert Schwarzenbacher, Martin Renatus et al. · Nature · 2001 · 411 citations · Full text